{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:03:13Z","timestamp":1790802193211,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.clbc.2026.09.003","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:26:58Z","timestamp":1789086418000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Core Outcome Set Measures Are Underreported in Breast Cancer Randomized Clinical Trials: A Cross-Sectional Study"],"prefix":"10.1016","volume":"26","author":[{"given":"Alexander","family":"Douglas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3585-3287","authenticated-orcid":false,"given":"Ty","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griffin","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigel","family":"Bacani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Moody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzeen","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Vassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2026.09.003_bib0001","unstructured":"WCRF International. Worldwide cancer data, 2022. https:\/\/www.wcrf.org\/cancer-trends\/worldwide-cancer-data\/. Accessed: May 31, 2023."},{"issue":"1","key":"10.1016\/j.clbc.2026.09.003_bib0002","first-page":"23","article-title":"Comparison of treatment costs for breast cancer, by tumor stage and type of service","volume":"9","author":"Blumen","year":"2016","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.clbc.2026.09.003_bib0003","unstructured":"National Cancer Institute. 2021 NCI budget fact book \u2013 research funding. 2022. https:\/\/www.cancer.gov\/about-nci\/budget\/fact-book\/data\/research-funding. Accessed: May 30, 2023."},{"key":"10.1016\/j.clbc.2026.09.003_bib0004","unstructured":"National Cancer Institute. 2022 NCI budget fact book \u2013 extramural programs, 2022. https:\/\/www.cancer.gov\/about-nci\/budget\/fact-book\/extramural-programs. Accessed: August 28, 2023."},{"issue":"33","key":"10.1016\/j.clbc.2026.09.003_bib0005","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2008.16.5456","article-title":"Evolution of the randomized controlled trial in oncology over three decades","volume":"26","author":"Booth","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2026.09.003_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060684","article-title":"Patient reported outcomes (PROs) in clinical trials: is \u201cin-trial\u201d guidance lacking? A systematic review","volume":"8","author":"Kyte","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.003_bib0007","first-page":"1","article-title":"The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders","volume":"4","author":"Rivera","year":"2020","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.clbc.2026.09.003_bib0008","unstructured":"COMET Initiative. https:\/\/www.comet-initiative.org\/ Accessed: June 2023."},{"issue":"3","key":"10.1016\/j.clbc.2026.09.003_bib0009","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/archdischild-2016-312117","article-title":"Core outcome sets","volume":"103","author":"Webbe","year":"2018","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"6","key":"10.1016\/j.clbc.2026.09.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099111","article-title":"Choosing important health outcomes for comparative effectiveness research: a systematic review","volume":"9","author":"Gargon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2026.09.003_bib0011","unstructured":"ICHOM Connect. Breast cancer. https:\/\/connect.ichom.org\/patient-centered-outcome-measures\/breast-cancer\/?_gl=1%2Anb2m04%2A_gcl_au%2AMTExOTc1NTEyMy4xNjg1NTc0NDgx Accessed: May 31, 2023."},{"issue":"1","key":"10.1016\/j.clbc.2026.09.003_bib0012","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-022-08694-9","article-title":"Balancing adaptability and standardisation: insights from 27 routinely implemented ICHOM standard sets","volume":"22","author":"Benning","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.clbc.2026.09.003_bib0013","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jamaoncol.2016.4851","article-title":"A standard set of value-based patient-centered Outcomes for breast cancer: the International Consortium for Health Outcomes Measurement (ICHOM) Initiative","volume":"3","author":"Ong","year":"2017","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.09.003_bib0014","doi-asserted-by":"crossref","DOI":"10.5195\/jmla.2017.88","article-title":"Open Science Framework (OSF)","volume":"105","author":"Foster","year":"2017","journal-title":"J Med Libr Assoc"},{"key":"10.1016\/j.clbc.2026.09.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j2262","article-title":"A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis","author":"Kirkham","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2026.09.003_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00864","article-title":"Breast cancer survivorship, quality of life, and late toxicities","volume":"10","author":"Nardin","year":"2020","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2026.09.003_bib0017","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1245\/s10434-016-5184-5","article-title":"Value-based breast cancer care: a multidisciplinary approach for defining patient-centered outcomes","volume":"23","author":"Fayanju","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2026.09.003_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041135","article-title":"Role of patient-reported outcomes in clinical trials in metastatic colorectal cancer: a scoping review","volume":"15","author":"Maring","year":"2023","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.clbc.2026.09.003_bib0019","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.clbc.2026.09.003_bib0020","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1001\/jama.2022.21022","article-title":"Guidelines for reporting outcomes in trial reports: the CONSORT-outcomes 2022 extension","volume":"328","author":"Butcher","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.clbc.2026.09.003_bib0021","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2012.46.6854","article-title":"American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care","volume":"31","author":"McCabe","year":"2013","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2026.09.003_bib0022","article-title":"Patient-reported outcome measures of breast cancer surgery: evidence review and tool adaptation","volume":"14","author":"Marzban","year":"2022","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.clbc.2026.09.003_bib0023","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1245\/s10434-018-6729-6","article-title":"Patient-reported outcome measures may add value in breast cancer surgery","volume":"25","author":"Lagendijk","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2026.09.003_bib0024","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.bjps.2016.06.004","article-title":"Quality of life following total mastectomy with and without reconstruction versus breast-conserving surgery for breast cancer: a case-controlled cohort study","volume":"69","author":"Howes","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.003_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1017\/S0022215117002420","article-title":"A systematic review of patient-reported outcome measures in paediatric otolaryngology","volume":"132","author":"Powell","year":"2018","journal-title":"J Laryngol Otol"},{"issue":"4","key":"10.1016\/j.clbc.2026.09.003_bib0026","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0895-4356(96)00428-3","article-title":"Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement","volume":"50","author":"Groenvold","year":"1997","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.clbc.2026.09.003_bib0027","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1200\/JCO.1997.15.3.974","article-title":"Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument","volume":"15","author":"Brady","year":"1997","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.003_bib0028","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12955-018-1012-x","article-title":"Assessing whether EORTC QLQ-30 and FACT-G measure the same constructs of quality of life in patients with total laryngectomy","volume":"16","author":"Iravani","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.clbc.2026.09.003_bib0029","unstructured":"ICHOM. Background and mission, 2018. https:\/\/www.ichom.org\/aboutus\/. Accessed: August 4, 2023."},{"key":"10.1016\/j.clbc.2026.09.003_bib0030","unstructured":"ICHOM. ICHOM FAQs \u2013 healthcare standardization & implementation FAQ\u2019s. 2018. https:\/\/www.ichom.org\/faqs\/. Accessed: July 22, 2023."},{"key":"10.1016\/j.clbc.2026.09.003_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2020.606246","article-title":"Harmonization of the ICHOM quality measures to enable health outcomes measurement in multimorbid patients","volume":"2","author":"Blom","year":"2020","journal-title":"Front Digit Health"},{"key":"10.1016\/j.clbc.2026.09.003_bib0032","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:24:22Z","timestamp":1790799862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1526820926001667"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.09.003","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Core Outcome Set Measures Are Underreported in Breast Cancer Randomized Clinical Trials: A Cross-Sectional Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}